Skip to main content

Head Sway Patterns Distinguish Vestibular Hypofunction From Healthy Controls

Medically reviewed by Carmen Pope, BPharm. Last updated on April 5, 2024.

By Lori Solomon HealthDay Reporter

FRIDAY, April 5, 2024 -- A head-mounted display test of postural control shows significant differences in head sway between participants with vestibular hypofunction (VH) and healthy controls, according to a pilot study published online Feb. 28 in Frontiers in Neurology.

Jennifer L. Kelly, P.T., from the New York Eye and Ear Infirmary of Mount Sinai in New York City, and colleagues investigated whether head sway can differentiate between patients with Meniere disease (MD; 18 participants), VH (32 participants), and healthy controls (30 participants).

The researchers found that when presented with a static visual, participants with VH showed significantly larger head sway using root mean square velocity (VRMS) compared with controls in the anterior-posterior (60 seconds and 20 seconds) and pitch (20 seconds) directions. When presented with a dynamic visual, participants with VH showed significantly larger head VRMS than controls for all directions for both the 60- and 20-second analysis. There were no significant differences for participants with MD versus the control or the VH group.

"Head sway derived from head-mounted display is sensitive to VH and can be clinically useful as an outcome measure to evaluate sensory integration for postural control," the authors write.

One author disclosed ties to the medical device industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Delayed Meniere Disease Tied to Higher Prevalence of Bilateral Disease

THURSDAY, Oct. 31, 2024 -- Delayed Meniere disease (DMD) is associated with a higher prevalence of bilateral Meniere disease (MD) compared with classic MD (CMD), according to a...

ACG: 2000 to 2022 Saw Rise in Early-Onset CRC Mortality in the United States

THURSDAY, Oct. 31, 2024 -- Early-onset colorectal cancer (EO-CRC) mortality rose in the United States over the past two decades, most notably in patients aged 20 to 44 years...

Cell-Free Blood DNA Tests Less Effective Than Other CRC Screening

WEDNESDAY, Oct. 30, 2024 -- Cell-free DNA blood tests (cf-bDNA) may be more costly and less effective for colorectal cancer (CRC) screening than other screening modalities...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.